Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00223041
Status:
TERMINATED
Last Update Posted:
2011-08-08
First Post:
2005-09-14
Brief Title:
Cranoc Lipid Study in Renal Transplantation
Sponsor:
University Hospital Schleswig-Holstein
Organization:
University Hospital Schleswig-Holstein
Study Overview
Official Title:
Cardiovascular Events in Renal Transplant Recipients With Low LDL-cholesterol Receiving Tacrolimus in Combination With the Statin Fluvastatin
Status:
TERMINATED
Status Verified Date:
2006-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
No possibilty to receive all plened patients for this study
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Cardiovascular disease after renal transplantation is an important problem Patients after renal transplantation with low LDL-Levels 130mgdl receive Fluvastatin 80mgday or no medication to look for the cardiovascular outcome with and without statins
Detailed Description:
Cardiovascular disease after renal transplantation is an important problem Patients after renal transplantation with low LDL-Levels 130mgdl receive Fluvastatin 80mgday or no medication to look for the cardiovascular outcome with and without statins
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None